MLTX vs. BHC, MRUS, MRVI, JANX, RYTM, DYN, ACAD, FOLD, RNA, and MOR
Should you be buying MoonLake Immunotherapeutics stock or one of its competitors? The main competitors of MoonLake Immunotherapeutics include Bausch Health Companies (BHC), Merus (MRUS), Maravai LifeSciences (MRVI), Janux Therapeutics (JANX), Rhythm Pharmaceuticals (RYTM), Dyne Therapeutics (DYN), ACADIA Pharmaceuticals (ACAD), Amicus Therapeutics (FOLD), Avidity Biosciences (RNA), and MorphoSys (MOR). These companies are all part of the "pharmaceutical preparations" industry.
MoonLake Immunotherapeutics (NASDAQ:MLTX) and Bausch Health Companies (NYSE:BHC) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership.
MoonLake Immunotherapeutics has higher earnings, but lower revenue than Bausch Health Companies. MoonLake Immunotherapeutics is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.
Bausch Health Companies received 303 more outperform votes than MoonLake Immunotherapeutics when rated by MarketBeat users. However, 77.42% of users gave MoonLake Immunotherapeutics an outperform vote while only 61.90% of users gave Bausch Health Companies an outperform vote.
93.9% of MoonLake Immunotherapeutics shares are owned by institutional investors. Comparatively, 78.7% of Bausch Health Companies shares are owned by institutional investors. 12.0% of MoonLake Immunotherapeutics shares are owned by company insiders. Comparatively, 8.1% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
MoonLake Immunotherapeutics has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500.
MoonLake Immunotherapeutics has a net margin of 0.00% compared to Bausch Health Companies' net margin of -5.07%. MoonLake Immunotherapeutics' return on equity of -7.92% beat Bausch Health Companies' return on equity.
MoonLake Immunotherapeutics currently has a consensus target price of $74.46, suggesting a potential upside of 91.66%. Bausch Health Companies has a consensus target price of $11.33, suggesting a potential upside of 70.94%. Given MoonLake Immunotherapeutics' stronger consensus rating and higher probable upside, analysts plainly believe MoonLake Immunotherapeutics is more favorable than Bausch Health Companies.
In the previous week, MoonLake Immunotherapeutics had 4 more articles in the media than Bausch Health Companies. MarketBeat recorded 9 mentions for MoonLake Immunotherapeutics and 5 mentions for Bausch Health Companies. MoonLake Immunotherapeutics' average media sentiment score of 0.34 beat Bausch Health Companies' score of 0.19 indicating that MoonLake Immunotherapeutics is being referred to more favorably in the media.
Summary
MoonLake Immunotherapeutics beats Bausch Health Companies on 13 of the 17 factors compared between the two stocks.
Get MoonLake Immunotherapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for MLTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MLTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MoonLake Immunotherapeutics Competitors List
Related Companies and Tools
